The sex ratio in amyotrophic lateral sclerosis: A population based study.

The sex ratio in amyotrophic lateral sclerosis: A population based study.

Replicable risk factors for ALS include increasing age, family history and being male. The male: female ratio has been reported as being between 1 and 3. We tested the hypothesis that the sex ratio changes with age in a population register covering the south-east of England. The sex ratio before and...

Podrobná bibliografie
Hlavní autoři:	Manjaly, Z, Scott, K, Abhinav, K, Wijesekera, L, Ganesalingam, J, Goldstein, L, Janssen, A, Dougherty, A, Willey, E, Stanton, B, Turner, M, Ampong, M, Sakel, M, Orrell, R, Howard, R, Shaw, C, Leigh, P, Al-Chalabi, A
Médium:	Journal article
Jazyk:	English
Vydáno:	2010

Podobné jednotky

The association between ALS and population density: A population based study.
Autor: Scott, K, a další
Vydáno: (2010)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
Autor: Scott, K, a další
Vydáno: (2009)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
Autor: Johnston, C, a další
Vydáno: (2006)

A proposed staging system for amyotrophic lateral sclerosis.
Autor: Roche, J, a další
Vydáno: (2012)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Autor: Turner, M, a další
Vydáno: (2002)

Amyotrophic lateral sclerosis
Autor: Leigh P Nigel, a další
Vydáno: (2009-02-01)

Evolution of white matter damage in amyotrophic lateral sclerosis
Autor: Gabel, M, a další
Vydáno: (2020)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Autor: Turner, M, a další
Vydáno: (2007)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
Autor: Abrahams, S, a další
Vydáno: (1997)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
Autor: Balendra, R, a další
Vydáno: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
Autor: Balendra, R, a další
Vydáno: (2015)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
Autor: Rutter-Locher, Z, a další
Vydáno: (2016)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
Autor: Turner, M, a další
Vydáno: (2020)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
Autor: Jones, A, a další
Vydáno: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
Autor: Balendra, R, a další
Vydáno: (2013)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
Autor: Kelly, M, a další
Vydáno: (2020)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
Autor: Balendra, R, a další
Vydáno: (2014)

Biomarkers in amyotrophic lateral sclerosis.
Autor: Turner, M, a další
Vydáno: (2009)

Large-scale pathways-based association study in amyotrophic lateral sclerosis.
Autor: Kasperaviciute, D, a další
Vydáno: (2007)

Large-scale pathways-based association study in amyotrophic lateral sclerosis
Autor: Kasperavičiute, D, a další
Vydáno: (2007)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
Autor: Turner, M, a další
Vydáno: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
Autor: Turner, M, a další
Vydáno: (2012)

Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.
Autor: Jeban Ganesalingam, a další
Vydáno: (2009-09-01)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
Autor: Jones, A, a další
Vydáno: (2014)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
Autor: Al-Chalabi, A, a další
Vydáno: (2003)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
Autor: Fang, F, a další
Vydáno: (2013)

Quantifying disease progression in amyotrophic lateral sclerosis.
Autor: Simon, N, a další
Vydáno: (2014)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
Autor: Turner, M, a další
Vydáno: (2011)

Evolution of white matter damage in amyotrophic lateral sclerosis
Autor: Matt C. Gabel, a další
Vydáno: (2020-05-01)

Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
Autor: Wicks, P, a další
Vydáno: (2008)

Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
Autor: Wicks, P, a další
Vydáno: (2005)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
Autor: Garcia-Gancedo, L, a další
Vydáno: (2019)

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
Autor: Morrison, K, a další
Vydáno: (2013)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
Autor: Turner, M, a další
Vydáno: (2013)

Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients.
Autor: Rio, A, a další
Vydáno: (2005)

Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability.
Autor: Vivekananda, U, a další
Vydáno: (2011)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
Autor: Yildiz, O, a další
Vydáno: (2025)

Psychiatric disorders prior to amyotrophic lateral sclerosis
Autor: Turner, M, a další
Vydáno: (2016)

A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis
Autor: McGeachan, AJ, a další
Vydáno: (2016)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
Autor: R.A.L. Menke, a další
Vydáno: (2018-01-01)